ACADIA PHARMACEUTICALS INC 4
4 · ACADIA PHARMACEUTICALS INC · Filed Nov 21, 2014
Insider Transaction Report
Form 4
Wells William McDowall
Director
Transactions
- Sale
Common Stock
2014-11-21$29.00/sh−5,810$168,490→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2014-11-21−5,810→ 9,117 totalExercise: $1.36Exp: 2022-06-07→ Common Stock (5,810 underlying) - Exercise/Conversion
Common Stock
2014-11-21$1.36/sh+5,810$7,902→ 5,810 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in March 2014.
- [F2]25% of the shares subject to the stock option vested and became exercisable at the end of each 3-month period following the date of grant of June 8, 2012.